To register your interest please contact [email protected] ... University's Medical School, and Massachusetts General Hospital through his professional career at the National Institute of ...

On Oct. 15, Modifi Bio, a Yale-based biotech company, closed an acquisition deal with Merck, an American pharmaceutical ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE ... MRNA), a biotechnology company based in ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Merck KGaA said it’s seeing the beginning of a post-Covid pandemic rebound in life sciences as it reaffirmed the group’s sales and profit guidance for the full year. The German science and ...

To support this growth, TileDB opened a new office in New York City, in addition to the company’s current headquarters in Cambridge, Massachusetts ... George was employed by Merck & Co., Inc. for 25 ...

To support this growth, TileDB opened a new office in New York City, in addition to the company's current headquarters in Cambridge, Massachusetts ... George was employed by Merck & Co., Inc. for 25 ...

Are you a print subscriber? Activate your account. By Garett Sloane - 2 hours 35 min ago By Gillian Follett - 2 hours 35 min ago By E.J. Schultz - 2 hours 35 min ago By Jack Neff - 2 hours 35 min ...

Oct 17 (Reuters) - German science and technology group Merck (MRCG.DE), opens new tab is open to more acquisitions for its Life Science business after announcing in May it would buy Mirus Bio for ...

Anyone crafting a bull case for the pharmaceutical giant Merck (NYSE: MRK) should include Keytruda as the company's best asset. The cancer drug has been Merck's top-selling medicine and its ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...